Press Resease

Muscle Relaxant Drugs Market - Global Industry Analysis

Muscle Relaxant Drugs Market By Drug Type (Facial Muscle Relaxant Drugs, Skeletal Muscle Relaxant Drugs, and Neuromuscular Blocking Agents) and By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy): Global Market Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Published Date: 19-Sep-2019 Category: Pharmaceutical Report Format : PDF Pages: 120 Report Code: ZMR-4752 Status : Published

Global muscle relaxant drugs market expected to generate around USD 5,815 million by 2025, at a CAGR of 7.6% between 2019 and 2025. The muscle relaxant drugs market is currently being driven by the ever-increasing popularization of anti-aging medicines among the global population and the rising trend of spas and salons.

Description

The report covers a forecast and an analysis of the global muscle relaxant drugs market on a global and regional level. The study provides historical data from 2017 to 2018 and a forecast from 2019 to 2025 based on revenue (USD Million). The study includes the drivers and restraints of the global muscle relaxant drugs market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the muscle relaxant drugs market on a global level.

In order to give the users a comprehensive view of the global muscle relaxant drugs market, we have included a competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Muscle Relaxant Drugs Market

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.

The study provides a decisive view of the global muscle relaxant drugs market is segmented based on drug type, distribution channel, and region. The regional segment includes North America, Latin America, Asia Pacific, Europe, and the Middle East and Africa.

Some main players in the muscle relaxant drugs market are Abbott Laboratories, Medtronic, Mallinckrodt, Vertical Pharmaceuticals, Par Sterile Products, Johnson & Johnson, SteriMax, and Endo Pharmaceuticals.

This report segments the global muscle relaxant drugs market into:

Global Muscle Relaxant Drugs Market: Drug Type Analysis

  • Facial Muscle Relaxant Drugs
  • Skeletal Muscle Relaxant Drugs
  • Neuromuscular Blocking Agents

Global Muscle Relaxant Drugs Market: Distribution Channel Analysis

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Global Muscle Relaxant Drugs Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Muscle Relaxant Drugs Market, 2017-2025 (USD Million)
    • 2.2. Global Muscle Relaxant Drugs Market: Snapshot
  •  
  • Chapter 3. Global Muscle Relaxant Drugs Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Prevalence of Low Back Pain
      • 3.2.2. Rising Geriatric Population
      • 3.2.3. Increasing demand for muscle relaxant for anti-aging treatment
    • 3.3. Market Restraints
      • 3.3.1. Introduction to alternate therapies
      • 3.3.2. Side effects of drugs
    • 3.4. Opportunities
      • 3.4.1. Strategic alliances formed by the market players
      • 3.4.2. Increasing awareness about the latest development
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis, by Drug Type
      • 3.6.2. Market attractiveness analysis, by Distribution Channel
      • 3.6.3. Market attractiveness analysis, by Region
  •  
  • Chapter 4. Global Muscle Relaxant Drugs Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Muscle Relaxant Drugs Market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New therapy launch
      • 4.2.3. Agreements, partnerships, collaborations, and joint ventures
      • 4.2.4. Research and development and regional expansion
  •  
  • Chapter 5. Global Muscle Relaxant Drugs Market - Drug Type analysis
    • 5.1. Global Muscle Relaxant Drugs Market: Drug Type overview
      • 5.1.1. Global Muscle Relaxant Drugs Market Revenue, by Drug Type, 2018 and 2025
    • 5.2. Facial Muscle Relaxant Drugs
      • 5.2.1. Global Muscle Relaxant Drugs Market for Facial Muscle Relaxant Drugs, 2017-2025 (USD Million)
    • 5.3. Skeletal Muscle Relaxant Drugs
      • 5.3.1. Global Muscle Relaxant Drugs Market for Skeletal Muscle Relaxant Drugs, 2017-2025 (USD Million)
    • 5.4. Neuromuscular Blocking Agents
      • 5.4.1. Global Muscle Relaxant Drugs Market for Neuromuscular Blocking Agents, 2017-2025 (USD Million)
  •  
  • Chapter 6. Global Muscle Relaxant Drugs Market - Distribution Channel Analysis
    • 6.1. Global Muscle Relaxant Drugs Market: Distribution Channel
      • 6.1.1. Global Muscle Relaxant Drugs Market Revenue, by Distribution Channel, 2018 and 2025
    • 6.2. Hospital Pharmacy
      • 6.2.1. Global Muscle Relaxant Drugs Market for Hospital Pharmacy, 2017-2025 (USD Million)
    • 6.3. Retail Pharmacy
      • 6.3.1. Global Muscle Relaxant Drugs Market for Retail Pharmacy, 2017-2025 (USD Million)
    • 6.4. Online Pharmacy
  • 6.4.1. Global Muscle Relaxant Drugs Market for Online Pharmacy, 2017-2025 (USD Million)
  •  
  • Chapter 7. Global Muscle Relaxant Drugs Market - Regional Analysis
    • 7.1. Global Muscle Relaxant Drugs Market: Regional overview
      • 7.1.1. Global Muscle Relaxant Drugs Market Revenue, by region, 2018 and 2025
    • 7.2. North America
      • 7.2.1. North America Muscle Relaxant Drugs Market Revenue, by Drug Type, 2017-2025 (USD Million)
      • 7.2.2. North America Muscle Relaxant Drugs Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
      • 7.2.3. The U.S.
        • 7.2.3.1. The U.S. Muscle Relaxant Drugs Market Revenue, by Drug Type, 2017-2025 (USD Million)
        • 7.2.3.2. The U.S. Muscle Relaxant Drugs Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
      • 7.2.4. Rest of North America
        • 7.2.4.1. Rest of North America Muscle Relaxant Drugs Market Revenue, by Drug Type, 2017-2025 (USD Million)
        • 7.2.4.2. Rest of North America Muscle Relaxant Drugs Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
    • 7.3. Europe
      • 7.3.1. Europe Muscle Relaxant Drugs Market Revenue, by Drug Type, 2017-2025 (USD Million)
      • 7.3.2. Europe Muscle Relaxant Drugs Market Revenue, by End -User, 2017-2025 (USD Million)
      • 7.3.3. UK
        • 7.3.3.1. UK Muscle Relaxant Drugs Market Revenue, by Drug Type, 2017-2025 (USD Million)
        • 7.3.3.2. UK Muscle Relaxant Drugs Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
      • 7.3.4. Germany
        • 7.3.4.1. Germany Muscle Relaxant Drugs Market Revenue, by Drug Type, 2017-2025 (USD Million)
        • 7.3.4.2. Germany Muscle Relaxant Drugs Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
      • 7.3.5. France
        • 7.3.5.1. France Muscle Relaxant Drugs Market Revenue, by Drug Type, 2017-2025 (USD Million)
        • 7.3.5.2. France Muscle Relaxant Drugs Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
      • 7.3.6. Rest of Europe
        • 7.3.6.1. Rest of Europe Muscle Relaxant Drugs Market Revenue, by Drug Type, 2017-2025 (USD Million)
        • 7.3.6.2. Rest of Europe Muscle Relaxant Drugs Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Muscle Relaxant Drugs Market Revenue, by Drug Type, 2017-2025 (USD Million)
      • 7.4.2. Asia Pacific Muscle Relaxant Drugs Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
      • 7.4.3. China
        • 7.4.3.1. China Muscle Relaxant Drugs Market Revenue, by Drug Type, 2017-2025 (USD Million)
        • 7.4.3.2. China Muscle Relaxant Drugs Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
      • 7.4.4. Japan
        • 7.4.4.1. Japan Muscle Relaxant Drugs Market Revenue, by Drug Type, 2017-2025 (USD Million)
        • 7.4.4.2. Japan Muscle Relaxant Drugs Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
      • 7.4.5. India
        • 7.4.5.1. India Muscle Relaxant Drugs Market Revenue, by Drug Type, 2017-2025 (USD Million)
        • 7.4.5.2. India Muscle Relaxant Drugs Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
      • 7.4.6. Rest of Asia Pacific
        • 7.4.6.1. Rest of Asia Pacific Muscle Relaxant Drugs Market Revenue, by Drug Type, 2017-2025 (USD Million)
        • 7.4.6.2. Rest of Asia Pacific Muscle Relaxant Drugs Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
    • 7.5. Latin America
      • 7.5.1. Latin America Muscle Relaxant Drugs Market Revenue, by Drug Type, 2017-2025 (USD Million)
      • 7.5.2. Latin America Muscle Relaxant Drugs Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
      • 7.5.3. Brazil
        • 7.5.3.1. Brazil Muscle Relaxant Drugs Market Revenue, by Drug Type, 2017-2025 (USD Million)
        • 7.5.3.2. Brazil Muscle Relaxant Drugs Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
      • 7.5.4. Rest of Latin America
        • 7.5.4.1. Rest of Latin America Muscle Relaxant Drugs Market Revenue, by Drug Type, 2017-2025 (USD Million)
        • 7.5.4.2. Rest of Latin America Muscle Relaxant Drugs Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
    • 7.6. The Middle East and Africa
      • 7.6.1. The Middle East and Africa Muscle Relaxant Drugs Market Revenue, by Drug Type, 2017-2025 (USD Million)
      • 7.6.2. The Middle East and Africa Muscle Relaxant Drugs Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
  •  
  • Chapter 8. Company Profile
    • 8.1. Abbott Laboratories
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Drug Type portfolio
      • 8.1.4. Business strategy
      • 8.1.5. Recent developments
    • 8.2. Medtronic
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Drug Type portfolio
      • 8.2.4. Business strategy
      • 8.2.5. Recent developments
    • 8.3. Mallinckrodt
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Drug Type portfolio
      • 8.3.4. Business strategy
      • 8.3.5. Recent developments
    • 8.4. Vertical Pharmaceuticals
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Drug Type portfolio
      • 8.4.4. Business strategy
      • 8.4.5. Recent developments
    • 8.5. Par Sterile Products
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Drug Type portfolio
      • 8.5.4. Business strategy
      • 8.5.5. Recent developments
    • 8.6. Johnson & Johnson
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Drug Type portfolio
      • 8.6.4. Business strategy
      • 8.6.5. Recent developments
    • 8.7. SteriMax
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Drug Type portfolio
      • 8.7.4. Business strategy
      • 8.7.5. Recent developments
    • 8.8. Endo Pharmaceuticals
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Drug Type portfolio
      • 8.8.4. Business strategy
      • 8.8.5. Recent developments

Methodology

Free Analysis

The skeletal muscle relaxant drugs are a heterogeneous group of medicines that acts both peripherally and centrally to relieve one from muscle spasms. Majorly the muscle relaxants are used to treat two conditions—muscular spasms or pain from injuries, such as low back pain or peripheral musculoskeletal diseases and spasticity from upper motor neuron syndromes that occur in multiple sclerosis.

The muscle relaxant drugs market is currently being driven by the ever-increasing popularization of anti-aging medicines among the global population and the rising trend of spas and salons. Increasing geriatric population, approval of fresh label signs, rising skin-related issues, and escalating surgeries performed worldwide are other main factors boosting the development of the market for muscle relaxant drugs market. However, some serious side-effects linked to use of muscle relaxing drugs, such as respiratory arrest and habituations, are likely to limit the worldwide expansion of the muscle relaxant drugs market. In the U.S., low back pain is among the most common causes of visits to a physician or doctor. On the other hand, doctors and physicians suggest skeletal muscle relaxants as a secondary treatment option for lower back pain. Although muscle relaxants medications are not the primary treatment option, about 40% patients in the U.S. are prescribed muscle relaxants for non-specific low back pain.

Global Muscle Relaxant Drugs Market

The muscle relaxant drugs market is fragmented based on drug type and distribution channel. By drug type, the market is divided into facial muscle relaxant drugs, neuromuscular blocking agents, and skeletal muscle relaxant drugs. Based on the distribution channel, the market for muscle relaxant drugs includes hospitals pharmacy, online pharmacy, and retail pharmacy.

North America accounted for a major share of the muscle relaxant drugs market globally in 2018 and is likely to remain dominant over the forecast time period. This regional dominance can be attributed to the growing number of new drug applications in North America and the regional presence of a large number of renowned companies. Europe held the second spot in the market for muscle relaxant drugs. The Asia Pacific is expected to register a high CAGR in the muscle relaxant drugs market globally over the estimated time period, owing to the growing base of the aging population in countries like Japan.

Some main players in the muscle relaxant drugs market are Abbott Laboratories, Medtronic, Mallinckrodt, Vertical Pharmaceuticals, Par Sterile Products, Johnson & Johnson, SteriMax, and Endo Pharmaceuticals.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social